Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1928 1
1948 2
1949 1
1955 1
1957 1
1958 1
1959 5
1960 4
1961 3
1962 4
1963 9
1964 8
1965 10
1966 2
1967 4
1968 5
1969 1
1970 5
1971 3
1972 4
1973 11
1974 2
1975 5
1976 5
1977 7
1978 10
1979 16
1980 19
1981 46
1982 45
1983 52
1984 56
1985 77
1986 87
1987 106
1988 123
1989 130
1990 163
1991 215
1992 251
1993 270
1994 339
1995 362
1996 395
1997 422
1998 491
1999 575
2000 735
2001 813
2002 1025
2003 1377
2004 1672
2005 2219
2006 2526
2007 2976
2008 3400
2009 4048
2010 5032
2011 5900
2012 6894
2013 8229
2014 9365
2015 10742
2016 11717
2017 12773
2018 14979
2019 17606
2020 21405
2021 24283
2022 29131
2023 28894
2024 33237
2025 36157
2026 582

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

270,956 results

Results by year

Filters applied: . Clear all
Page 1
Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.
Yang Q, Xue B, Qiu X, Yang K, Tang J, Zhou A, Zou J, Mao Y, Zhong J, Zhou Y, Zhang W, Zhang Q, Xiao Q, Tang W, Li Z, Ye W, Zou G, Peng W, Shang J, Xu X, Li Y, Chen X. Yang Q, et al. Among authors: li y. J Virol. 2025 Dec 9:e0148725. doi: 10.1128/jvi.01487-25. Online ahead of print. J Virol. 2025. PMID: 41364004
Long-term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial.
Zhang J, Zhang Y, Qiu H, Zhou Y, Zhou Y, Zhang X, Zhou Y, Zhu Y, Li Y, Wang M, Shen K, Tao K, Wu X, Wang H, Zhang B, Ling J, Ye Y, Wu X, Qu H, Ma Y, Jiao X, Zheng H, Jin J, Liu Z, An Z, Zhang P, Liu P, Lei C, Cai Z, Gao Z, Shen L, Li J. Zhang J, et al. Among authors: li y. Cancer. 2025 Dec 1;131 Suppl 3:e70150. doi: 10.1002/cncr.70150. Cancer. 2025. PMID: 41363834 Clinical Trial.
Chinese expert consensus on diagnosis and treatment of small gastrointestinal stromal tumors (2025 edition).
Gao Z, Wang C, Li J, Zhang P, Wu X, Wang Y, Zhang L, Chen T, Zhang B, Wang M, Qian H, Zhou Y, Li S, Sun Y, Liang H, He Y, Li Y, Cao H, Qin S, Shen L, Ye Y; Chinese Society of Clinical Oncology (CSCO) Expert Committee on Gastrointestinal Stromal Tumor. Gao Z, et al. Among authors: li y. Cancer. 2025 Dec 1;131 Suppl 3:e70152. doi: 10.1002/cncr.70152. Cancer. 2025. PMID: 41363821 Review.
270,956 results
You have reached the last available page of results. Please see the User Guide for more information.